Tejnaksh Healthcare Limited was incorporated in Mumbai on 18 February, 2008 as a Private Limited Company and converted into Public Limited Company with effect from 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra. Tejnaksh runs an Institute of Urology, an ISO certified the international level Urology hospital, located in Dhule, Maharashtra. It provides a complete range of services from consultations and investigations to treatment for Urology. The main objective of Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate.
Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Company`s achievements were the multiple records that motivates the customers to improve treatment for Urology.
In 2005, the Company started the 1st Urodynamics Lab of North Maharashtra. In 2006 , it established First Urology CME for the amily physicians. In 2007, it set up 1st Laser Unit and 1st Flexible Ureteroscope of North Maharashtra. In 2009, the Company was into Urology and healthcare training, recognized by The National Board of Examination.
In October 2015, the Company made a public issue of 3,04,000 Equity Shares of Rs 10/- each by raising funds aggregating to Rs. 2.44 Crores.
In 2015, the Company hosted the first PCNL workshop and became a public limited company. During the same year, the Company first dental speciality clinic took the initiative to set up The International Health Tourism.
In 2016, Company set up the first indigenous PCNL simulation lab in the country and were made commercially available. Further, Company started Urology and Dental centers at Malegaon (MS), Sendhwa (MP) and a multi-speciality center at Navi Mumbai in 2016.
Tejnaksh Healthcare share price as on 02 Mar 2026 is Rs. 13.4. Over the past 6 months, the Tejnaksh Healthcare share price has decreased by 26.78% and in the last one year, it has decreased by 41.99%. The 52-week low for Tejnaksh Healthcare share price was Rs. 12.55 and 52-week high was Rs. 24.77.
Tejnaksh Healthcare Limited was incorporated in Mumbai on 18 February, 2008 as a Private Limited Company and converted into Public Limited Company with effect from 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra. Tejnaksh runs an Institute of Urology, an ISO certified the international level Urology hospital, located in Dhule, Maharashtra. It provides a complete range of services from consultations and investigations to treatment for Urology. The main objective of Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate.
Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Company`s achievements were the multiple records that motivates the customers to improve treatment for Urology.
In 2005, the Company started the 1st Urodynamics Lab of North Maharashtra. In 2006 , it established First Urology CME for the amily physicians. In 2007, it set up 1st Laser Unit and 1st Flexible Ureteroscope of North Maharashtra. In 2009, the Company was into Urology and healthcare training, recognized by The National Board of Examination.
In October 2015, the Company made a public issue of 3,04,000 Equity Shares of Rs 10/- each by raising funds aggregating to Rs. 2.44 Crores.
In 2015, the Company hosted the first PCNL workshop and became a public limited company. During the same year, the Company first dental speciality clinic took the initiative to set up The International Health Tourism.
In 2016, Company set up the first indigenous PCNL simulation lab in the country and were made commercially available. Further, Company started Urology and Dental centers at Malegaon (MS), Sendhwa (MP) and a multi-speciality center at Navi Mumbai in 2016.
Tejnaksh Healthcare share price as on 02 Mar 2026 is Rs. 13.4. Over the past 6 months, the Tejnaksh Healthcare share price has decreased by 26.78% and in the last one year, it has decreased by 41.99%. The 52-week low for Tejnaksh Healthcare share price was Rs. 12.55 and 52-week high was Rs. 24.77.
